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BRIEF REPORT: PREVENTION SCIENCE
PrEP Uptake, Adherence, and Discontinuation Among
California YMSMUsing Geosocial Networking Applications
Ian W. Holloway, MSW, MPH, PhD,* Ryan Dougherty, BS,* Jennifer Gildner, MS,*
Sean C. Beougher, MA,* Craig Pulsipher, MSW, MPP,† Jorge A. Montoya, PhD,‡
Aaron Plant, MPH,‡ and Arleen Leibowitz, PhD*
Abstract: We investigated pre-exposure prophylaxis (PrEP) uptake,
adherence, and discontinuation among young app-using men who
have sex with men in California (N = 761). Approximately, 9.7% of
participants had ever used PrEP; 87% of those deemed good
candidates for screening (indicated by a Centers for Disease Control
and Prevention risk index score $10) were not current or past users.
PrEP use was associated with higher income [adjusted odds ratio
(aOR): 4.13; conﬁdence interval (CI): 1.87 to 9.12], receptive
condomless anal sex (aOR: 3.41; CI: 1.71 to 6.78), HIV-positive
sex partners (aOR: 2.87; CI: 1.53 to 5.38), popper use (aOR: 3.47; CI:
1.96 to 6.13), and recent sexually transmitted infection diagnosis
(aOR: 2.90; CI: 1.64 to 5.13). Some users (41.5%) wanted help
remembering to take PrEP. The top reason for discontinuation was
concern about long-term side effects (33.0%). Young men who have
sex with men app users are prime candidates for PrEP, despite low
uptake. Apps may be useful tools for PrEP information dissemination,
adherence monitoring, and support.
Key Words: PrEP, PrEP uptake, PrEP adherence, PrEP discontin-
uation, young men who have sex with men, geosocial networking
applications
(J Acquir Immune Deﬁc Syndr 2017;74:15–20)
INTRODUCTION
Across the US, cities, counties, and states are developing
plans for “Getting to Zero” new HIV infections.1,2 These plans
rely on 2 strategies: (1) routinizing HIV testing in high-risk
communities, linking to care those who test positive, and
suppressing viral load among those who are already
HIV-positive; and (2) avoiding new infections using a variety
of prevention approaches, such as pre-exposure prophylaxis
(PrEP). Unfortunately, although much is known about increas-
ing and sustaining engagement in HIV care, less is known
about uptake of, adherence to, and the factors that support or
hinder long-term use of PrEP.3
In California, as elsewhere in the US, HIV incidence is
increasing among young men who have sex with men
(YMSM), especially YMSM of color.4 Recent estimates
attribute two-thirds of all new HIV infections to men who
have sex with men (MSM),4,5 with nearly one-third of those
infected aged 20–29 years.4 Studies suggest that YMSM who
use geosocial networking apps (GSN apps) may be at increased
risk for HIV6 because of their having higher numbers of sex
partners,7 more frequent condomless anal sex (CAS),8–10 and
greater incidence of sexually transmitted infections (STIs)7,10,11
compared to those who do not use GSN apps.
Although some research into willingness to engage in
PrEP has focused on GSN app users,12 there are relatively few
studies that measure PrEP uptake in this demographic, and
research examining PrEP usage has been largely limited to
participants in clinical settings.13–17 Although PrEP uptake is
increasing, overall estimates remain low, with previous studies
ﬁnding fewer than 5% of sampled MSM having ever taken
it.18–24 These estimates, however, are mostly based on ﬁndings
from studies in eastern cities,23,25,26 leaving estimates on PrEP
uptake among YMSM in California—the state with the largest
number of new HIV infections each year27—largely unknown.
Although PrEP is recommended by the Centers for Disease
Control and Prevention (CDC) for high-risk MSM,28 past studies
document numerous barriers to uptake among YMSM, including
cost, availability, and fears of risk compensation (ie, increased
risk behavior triggered by decreased perception of risk).29–31 Data
from clinical trials suggest factors inﬂuencing PrEP use and
adherence are not well-identiﬁed,32 and questions remain about
how to motivate uptake of and sustain adherence to PrEP for HIV
prevention.33 This study sought to understand current rates and
correlates of PrEP uptake, adherence, and discontinuation among
YMSM who use GSN apps.
METHODS
Participants and Procedures
This analysis used data from an online survey con-
ducted from July 9 to August 20, 2015. Participants were
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recruited through several popular GSN apps using pop-up
messaging and banner ads targeting users aged 18–29 years in
California. YMSM interested in the study completed an
eligibility screener conﬁrming they were HIV-negative,
a California resident, and between 18 and 29 years; it also
conﬁrmed their sex at birth as male and that they had male sex
partners within the past 5 years. Completing the survey took
approximately 20 minutes. Participants were compensated
with $20 electronic gift cards for their time. All study
procedures were approved by the UCLA North Campus
Institutional Review Board.
Measures
The survey queried demographic information, including
race/ethnicity, age, gender identity, sexual orientation, sexual
behavior, current employment, highest level of education,
annual income, current insurance coverage, homelessness in
the past 12 months, and US citizenship. Questions regarding
sexual risk behavior in the past 6 months included number of
male sexual partners, number of instances of receptive CAS,
and insertive CAS with an HIV-positive partner, number of
HIV-positive partners, and ever exchanging sex for money.
Other risk factors measured were STI diagnoses in the past
year, substance use in the last 6 months, last HIV/STI test,
and perceived risk for and concern about contracting HIV.
Using 6 of these risk measures, we calculated the MSM
risk index based on the CDC’s recommendations.34 This risk
index considers age, number of male partners, HIV-positive
partners, receptive CAS, insertive CAS with an HIV-positive
partner, and methamphetamine use as factors in calculating
a risk score (which can range from 0 to 45). Those with
scores $10 on this scale warrant evaluation for intensive HIV
prevention services, including PrEP. Participants were also
asked if they had ever taken PrEP. Those who had taken PrEP
were asked if they were current users and about their
experience using PrEP; those who had stopped taking PrEP
were asked why.
Data Analysis
Bivariate x2 tests were performed comparing demo-
graphics and risk behaviors of those who had ever versus
those who had never taken PrEP to determine variables of
interest for multivariate modeling. In cases where sample size
was too small, Fisher exact test was performed. We used the
Benjamini and Hochberg procedure, which ranks P-values
from most to least signiﬁcant, to control for false discovery at
the 0.05 signiﬁcance level.35 Statistically signiﬁcant variables
at the bivariate level were included in a multivariate logistic
regression model of PrEP uptake; stepwise regression was
used to arrive at the ﬁnal model.
RESULTS
We screened 3868 survey respondents, of which 1777
met our inclusion criterion. Our ﬁnal sample of complete
surveys included 761 California MSM aged 18–29 years who
were sexually active in the past 5 years and had never been
diagnosed with HIV/AIDS. Less than 10% of participants
(9.7%) reported ever taking PrEP, with 71.6% of those who
had ever taken PrEP being current users. Mean participant age
was 23 years (SD = 3.2) with a smaller percentage of younger
participants (age 18–24 years) having ever taken PrEP
(48.6%) compared to older participants (age 25–29 years)
(63.2%, P , 0.05). The sample was racially/ethnically
diverse, and there were no statistically signiﬁcant differences
in PrEP uptake by race/ethnicity. Most men were identiﬁed as
gay (81.9%); among PrEP users, nearly all were gay
identiﬁed (97.3%). Among those who had ever taken PrEP,
55.4% reported annual salaries $$30,000 compared to those
who had never taken PrEP (28.5%). A higher percentage of
those who had ever taken PrEP were currently insured
(86.5%) compared to those who had never used PrEP
(74.1%; P , 0.05).
In general, PrEP users engaged in higher levels of HIV-
risk behavior than non-PrEP users. A greater percentage of
those who had ever used PrEP reported 6 or more sexual
partners within the past 6 months (71.6%) compared to those
who had never used PrEP (37.0%; P , 0.001). Similarly,
greater percentages of PrEP users reported recent receptive
CAS (82.4%) and insertive CAS with an HIV-positive partner
(43.2%) than those who had never taken PrEP (52.4% and
22.0%, respectively; P , 0.001). Higher percentages of PrEP
users reported using poppers (63.5% vs. 21.5%) and other
illicit drugs in the last 6 months (41.9% vs. 16.9%; P, 0.001
in both cases) and testing positive for an STI within the past
year (55.4% vs. 19.5%; P , 0.001) compared to those who
had never taken PrEP. A full list of bivariate correlates of
PrEP uptake is listed in Table 1.
Multivariate Correlates of PrEP Uptake
After adjusting for other variables in the model, those
making $$30,000 had greater odds of being PrEP users
compared to those making ,$10,000 per year [adjusted odds
ratio (aOR): 4.13, conﬁdence interval (CI): 1.87 to 9.12, P ,
0.001]. Receptive CAS in the last 6 months was positively
associated with PrEP use (aOR: 3.41, CI: 1.71 to 6.78, P ,
0.001). Those who reported sex with an HIV-positive partner
in the last 6 months had greater odds of being PrEP users
compared to those without an HIV-positive partner (aOR: 2.87,
CI: 1.53 to 5.38, P = 0.001). YMSM who used poppers in the
last 6 months had greater odds of being a PrEP user compared
to those who did not use poppers (aOR: 3.47, CI: 1.96 to 6.13,
P , 0.001). Finally, an STI diagnosis in the past year was
associated with being a PrEP user (aOR: 2.90, CI: 1.64 to 5.13,
P , 0.001). Table 2 contains multivariate results.
Reasons for PrEP Initiation and
PrEP Adherence
For those who had ever taken PrEP (n = 74), the top 5
reasons for initiating PrEP were as follows: (1) wanting to
worry less about getting HIV (71.6%), (2) having more than 1
sexual partner (66.2%), (3) not always using condoms
(52.7%), (4) having sex with people whose HIV status the
participant did not know (50.0%), and (5) disliking condoms
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TABLE 1. Participant Characteristics Among YMSM in California by PrEP Use (N = 761)
Variable
Total Ever Used PrEP Never Used PrEP
x2 (P)*N (%) N (%) N (%)
Total 761 (100.0) 74 (9.7) 687 (90.3)
Demographic characteristics
Age 6.0 (0.02)
18–24 470 (61.8) 36 (48.6) 434 (63.2)
25–29 291 (38.2) 38 (51.4) 253 (36.8)
Race/ethnicity 6.1 (0.11)
White 165 (21.7) 23 (31.1) 142 (20.7)
Black/African American 193 (25.4) 19 (25.7) 174 (25.3)
Hispanic/Latino 243 (31.9) 16 (21.6) 227 (33.0)
Other/mixed 160 (21.0) 16 (21.6) 144 (21.0)
Gender identity (0.29)
Male 742 (97.5) 73 (98.6) 669 (97.4)
Other 19 (2.5) 1 (1.4) 18 (2.6)
Sexual orientation 13.5 (0.001)
Gay 623 (81.9) 72 (97.3) 551 (80.2)
Bisexual 120 (15.8) 1 (1.4) 119 (17.3)
Other 18 (2.4) 1 (1.4) 17 (2.5)
Education 4.3 (0.12)
Less than high school 45 (5.9) 1 (1.4) 44 (6.4)
Completed high school 155 (20.4) 12 (16.2) 143 (20.8)
Some college and above 556 (73.1) 60 (81.1) 496 (72.2)
Employment 4.4 (0.22)
Employed full-time 311 (40.9) 38 (51.4) 273 (39.7)
Employed part-time 170 (22.3) 13 (17.6) 157 (22.9)
Full-time student 181 (23.8) 13 (17.6) 168 (24.5)
Other 99 (13.0) 10 (13.5) 89 (13.0)
Income 19.5 (,0.001)
,$9999 186 (24.4) 10 (13.5) 176 (25.6)
$10,000–29,999 275 (36.1) 21 (28.4) 254 (37.0)
.$30,000 237 (31.1) 41 (55.4) 196 (28.5)
Current insurance 573 (75.3) 64 (86.5) 509 (74.1) 5.5 (0.02)
Homeless in the last 12 mo 54 (7.1) 7 (9.5) 47 (6.8) 0.7 (0.41)
US citizen 684 (89.9) 68 (91.9) 616 (89.7) 0.1 (0.81)
Sexual risk and protective factors
6 or more male sex partners in the last 6 mo 307 (40.3) 53 (71.6) 254 (37.0)
Had receptive anal sex with a man without a condom
in the last 6 mo
421 (55.3) 61 (82.4) 360 (52.4) 24.4 (,0.001)
Had an HIV positive male partner in the last 6 mo 99 (13.0) 26 (35.1) 73 (10.6) 35.5 (,0.001)
Had insertive anal sex without a condom with an
HIV-positive man in last 6 mo
183 (24.0) 32 (43.2) 151 (22.0) 16.5 (,0.001)
Ever exchanged sex for money, drugs, or place to stay 90 (11.8) 11 (14.9) 79 (11.5) 0.7 (0.39)
Last HIV test 49.8 (,0.001)
,6 mo ago 426 (56.0) 70 (94.6) 356 (51.8)
6–12 mo ago 144 (18.9) 2 (2.7) 142 (20.7)
.12 mo ago 97 (12.7) 2 (2.7) 95 (13.8)
I have never been tested 94 (12.4) 94 (13.7)
STI diagnosis in the past year 175 (23.0) 41 (55.4) 134 (19.5) 48.6 (,0.001)
Last STI test 46.0 (,0.001)
,6 mo ago 397 (52.2) 66 (89.2) 331 (48.2)
6–12 mo ago 160 (21.0) 6 (8.1) 154 (22.4)
.12 mo ago 112 (14.7) 2 (2.7) 110 (16.0)
I have never been tested 92 (12.1) 92 (13.4)
How would you rate your risk of getting HIV 29.0 (,0.001)
(continued on next page)
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(32.4%). Smaller percentages reported having PrEP recom-
mended to them by a doctor or health care provider (29.7%),
a friend (23.0%), or a sex partner (12.2%).
Among current PrEP users (n = 53), 92.5% reported
taking PrEP 6–7 days per week. However, 41.5% indicated
that they wanted help remembering to take PrEP. The average
amount participants spent on PrEP, including clinical ancil-
lary costs, was $88 monthly. Half (50.9%) received ﬁnancial
assistance and a quarter (24.5%) indicated wanting additional
help paying for PrEP.
Reasons for Discontinuing PrEP
Among those who discontinued PrEP (n = 21), the top 5
reasons for discontinuing were as follows: (1) being concerned
about the consequences of long-term PrEP use (33.3%), (2)
being unable to afford a prescription for PrEP (28.6%), (3)
using other strategies to reduce HIV risk (23.8%), (4)
forgetting to take PrEP everyday (23.8%), and (5) being
unable to afford the required medical visits for PrEP (19.0%).
DISCUSSION
PrEP implementation is crucial to advancing the goals of
the National HIV/AIDS Strategy36 and forthcoming California
statewide plan for “Getting to Zero.”37 Our study provides
insights into current rates and correlates of PrEP uptake and
reasons for initiation and discontinuation of PrEP among YMSM
who use GSN apps. Overall, PrEP uptake remains low (9.7%),
which is consistent with other studies of YMSM.18,23 Although
uptake is increasing, much remains to be done to increase PrEP
usage among this high-priority population.38
In our multivariate analysis, higher income was signif-
icantly associated with PrEP usage. These results, coupled
with those indicating discontinuation of PrEP related to cost,
underscore the need for programs and policies that offset the
cost of taking PrEP. Programs that seek to enroll YMSM in
insurance, along with co-payment assistance programs,39 are
2 strategies to reduce barriers among low-income YMSM.
Several states, including New York, Colorado, and Wash-
ington, have implemented publicly funded programs to pay
for PrEP—a strategy that ultimately may be cost-saving.40
The remaining correlates of PrEP uptake were related to
individual risk behaviors, such as receptive CAS, sex with an
HIV-positive partner, and popper use, which often accom-
panies high-risk sexual behaviors.41 Although these
cross-sectional results do not necessarily represent risk
compensation among PrEP users, they may indicate PrEP is
reaching many YMSM who are good candidates, as both
CAS and sex with HIV-positive partners are screening
TABLE 1. (Continued ) Participant Characteristics Among YMSM in California by PrEP Use (N = 761)
Variable
Total Ever Used PrEP Never Used PrEP
x2 (P)*N (%) N (%) N (%)
Low 315 (41.4) 18 (24.3) 297 (3.2)
Moderate 318 (41.8) 30 (40.5) 288 (41.9)
High 94 (12.4) 23 (31.1) 71 (10.3)
How concerned are you about becoming infected with
HIV
3.9 (0.14)
Not concerned 197 (25.9) 16 (21.6) 181 (26.3)
Somewhat concerned 235 (30.9) 18 (24.3) 217 (31.6)
Very concerned 329 (43.2) 40 (54.1) 289 (42.1)
HIV-risk score based on CDC screener 25.3 (,0.001)
Low (,10) 237 (31.1) 4 (5.4) 233 (33.9)
High ($10) 524 (68.9) 70 (94.6) 454 (66.1)
Substance use (last 6 mo)
Alcohol 589 (77.4) 60 (81.1) 529 (77.0) 0.6 (0.43)
Marijuana/pot 334 (43.9) 35 (47.3) 299 (43.5) 0.4 (0.53)
Poppers 195 (25.6) 47 (63.5) 148 (21.5) 61.7 (,0.001)
Illicit drug use (ie, heroin, cocaine/crack,
methamphetamine/crystal, GHB, ecstasy/MDMA/
Molly, ketamine/K)
147 (19.3) 31 (41.9) 116 (16.9) 26.8 (,0.001)
*Fisher exact test was performed where cell sizes were small.
GHB, gamma-hydroxybutyric acid; MDMA, Methylenedioxymethamphetamine.
TABLE 2. Multivariate Logistic Regression Analysis of PrEP
Uptake Among YMSM in California (N = 698)*
Odds Ratio 95% CI P
Annual income
,$10,000 Ref.
$10,000–29,000 1.35 0.59 to 3.12 0.478
$30,000 or more 4.13 1.87 to 9.12 ,0.001
Receptive CAS in the last 6 mo 3.41 1.71 to 6.78 ,0.001
HIV positive partner in the last 6 mo 2.87 1.53 to 5.38 0.001
Substance use in the last 6 mo: poppers 3.47 1.96 to 6.13 ,0.001
Any STI diagnosis in the past year 2.90 1.64 to 5.13 ,0.001
*Sixty-three individuals were excluded because of missing income.
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questions on the CDC’s tool to evaluate for intensive HIV
prevention services.28 The CDC tool omits popper use as
a screening question, although recommended in predicting
HIV incidence among MSM.34
Although not statistically signiﬁcant in multivariate
modeling, a greater percentage of PrEP users perceived
themselves at high risk for HIV compared to non-PrEP users.
These results point to the need for targeted strategies for
identifying YMSM candidates for PrEP based on their risk
perception and behavioral risk proﬁle. In our study, 87% of
those deemed good candidates for PrEP screening (indicated
by a score $10 on the CDC risk index) were not current or
past PrEP users. Although it is important to educate and
encourage health providers to ask their patients about sexual
risk and PrEP, using GSN apps to disseminate information
regarding PrEP, including where to go for PrEP, is warranted.
Self-reported PrEP adherence was high in our sample
(.90%)—efﬁcacy studies with MSM show that PrEP can be
up to 96% effective even when taken only 4 times weekly42—
and may overestimate actual adherence, especially in light of
the fact that nearly one-quarter of former users stated that
difﬁculty remembering to take PrEP was a reason they
discontinued it. Technology-supported adherence methods
that have been successful in increasing antiretroviral adher-
ence may also be leveraged to support PrEP adherence.43,44
This study is among the ﬁrst to measure PrEP uptake
among a sample of YMSM in California. Data point to the
need for increasing PrEP uptake through targeted messaging to
YMSM GNS app users engaged in high-risk sexual behaviors.
Developing programs and policies that offset the cost for low-
income YMSM is a high priority for increasing PrEP uptake.
This sample is not representative of all YMSM who use GSN
apps and all data relies on self-report. Further research using
medical records to track PrEP uptake and/or more sophisticated
measures of adherence is warranted. Despite limitations, this
study points to the importance of increased outreach to YMSM
using GSN apps for PrEP information dissemination and
adherence monitoring and support.
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